Gilead under fire for AIDS drugs price rises…
Gilead Sciences is poised to expand its pipeline of cancer and inflammatory drugs with its planned acquisition of YM BioScien -More- …
FOSTER CITY, Calif. & MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Gilead Sciences, Inc. (GILD) and YM BioSciences Inc. (NYSE MKT: YMI, TSX: YM) announced today that the companies have signed a definit…
Gilead to buy YM for $510 million…